Stock HALO HALOZYME THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Halozyme Therapeutics, Inc.

Equities

HALO

US40637H1095

Market Closed - Nasdaq
Other stock markets
 21:00:00 09/05/2024 BST 		5-day change 1st Jan Change
43.84 USD +4.36% Intraday chart for Halozyme Therapeutics, Inc. +10.10% +18.61%
05-07 Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed MT
05-07 Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
HALOZYME THERAPEUTICS, INC. Stock Halozyme Therapeutics, Inc.
 5.34B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 23.46B -
BIONTECH SE Stock BioNTech SE
 21.72B -
GENMAB A/S Stock Genmab A/S
 18.64B
  1. Stock Market
  2. Equities
  3. HALO Stock
  4. Charts Halozyme Therapeutics, Inc.
  5. Sector Chart